Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy.
暂无分享,去创建一个
J P Miller | J. Miller | J. Baty | S. Pandya | J. Florence | W. King | J. Robison | J Baty | J. Schierbecker | L. Signore | S Pandya | J M Florence | W M King | J D Robison | J Schierbecker | L C Signore | J. Florence | J. Schierbecker | Jackson N. Baty | Jack Baty | J. Schierbecker | Julaine Florence | Shree Pandya | Wendy M. King | J Philip Miller
[1] Jacob Cohen,et al. Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit. , 1968 .
[2] J. Miller,et al. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. , 1987, Archives of neurology.
[3] R. Sitgreaves. Psychometric theory (2nd ed.). , 1979 .
[4] J. Fleiss. The design and analysis of clinical experiments , 1987 .
[5] Wakim Kg,et al. Objective recording of muscle strength. , 1950 .
[6] W. Stuberg,et al. Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. , 1988, Physical therapy.
[7] A. Pestronk,et al. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. , 1991, Archives of neurology.
[8] M. Province,et al. Clinical investigation in duchenne dystrophy. VI. Double‐blind controlled trial of nifedipine , 1987, Muscle & nerve.
[9] W. A. Spencer,et al. Muscle Testing: Part 2. Reliability in Clinical Use , 1961 .
[10] V. Dubowitz,et al. Intellect and Behaviour in Duchenne Muscular Dystrophy , 1981, Developmental medicine and child neurology.
[11] J. Miller,et al. Statistical considerations in clinical trials , 1990, Muscle & nerve.
[12] M. Province,et al. Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures. , 1984, Physical therapy.
[13] J. Miller,et al. Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E , 1988, Muscle & nerve.
[14] J. Mendell,et al. Manual muscle testing , 1990, Muscle & nerve.
[15] D. Cicchetti,et al. A Computer Program for Assessing Specific Category Rater Agreement for Qualitative Data , 1978 .
[16] F. H. Tyler,et al. Assessment of muscle strength in Duchenne muscular dystrophy , 1977, Neurology.
[17] L. Blair. The role of the physical therapist in the evaluation studies of the poliomyelitis vaccine field trials. , 1957, The Physical therapy review.
[18] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[19] J. Miller,et al. Clinical investigation in duchenne muscular dystrophy: IV. Double. Blind controlled trial of leucine , 1984, Muscle & nerve.
[20] A. Lilienfeld,et al. A study of the reproducibility of muscle testing and certain other aspects of muscle scoring. , 1954, The Physical therapy review.
[21] J. Miller,et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.
[22] M A Province,et al. Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. , 1987, Archives of neurology.
[23] B. J. Norton,et al. Clinical reliability of manual muscle testing. Middle trapezius and gluteus medius muscles. , 1987, Physical therapy.
[24] T. Partridge. Invited review: Myoblast transfer: A possible therapy for inherited myopathies? , 1991, Muscle & nerve.
[25] J. B. Merrill,et al. PHYSICAL THERAPY IN INFANTILE PARALYSIS , 1933 .
[26] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[27] J. Miller,et al. Duchenne muscular dystrophy , 1989, Neurology.
[28] L. Kunkel,et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts , 1989, Nature.
[29] M. Silver,et al. Further standardization of manual muscle test for clinical study: applied in chronic renal disease. , 1970, Physical therapy.
[30] C. Wiles. Quantification of neurologic deficit , 1990 .
[31] J. Miller,et al. Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history , 1983, Muscle & nerve.
[32] M. Brooke,et al. Randomized, double‐blind trial of mazindol in Duchenne dystrophy , 1990, Muscle & nerve.
[33] A. Sapega,et al. Factors influencing manual muscle tests in physical therapy. , 1978, The Journal of bone and joint surgery. American volume.
[34] D. Downham,et al. Practical analysis of variability of muscle function measurements in duchenne muscular dystrophy , 1987, Muscle & nerve.
[35] W. G. Wright,et al. Muscle Training in the Treatment of Infantile Paralysis , 1912 .
[36] A. Pestronk,et al. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. , 1991, Archives of neurology.
[37] M. Brooke,et al. Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.
[38] J. M. Rothstein. Measurement in physical therapy , 1985 .